AirSculpt Technologies/$AIRS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AirSculpt Technologies
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
Ticker
$AIRS
Sector
Primary listing
Employees
406
Headquarters
Website
AIRS Metrics
BasicAdvanced
$681M
-
-$0.25
2.54
-
Price and volume
Market cap
$681M
Beta
2.54
52-week high
$12.00
52-week low
$1.53
Average daily volume
988K
Financial strength
Current ratio
0.635
Quick ratio
0.387
Long term debt to equity
89.276
Total debt to equity
93.579
Interest coverage (TTM)
-1.34%
Profitability
EBITDA (TTM)
4.156
Gross margin (TTM)
63.32%
Net profit margin (TTM)
-8.79%
Operating margin (TTM)
-5.17%
Effective tax rate (TTM)
3.49%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
-2.61%
Return on equity (TTM)
-16.47%
Valuation
Price to revenue (TTM)
3.878
Price to book
7.47
Price to tangible book (TTM)
-22.84
Price to free cash flow (TTM)
-3,234.269
Free cash flow yield (TTM)
-0.03%
Free cash flow per share (TTM)
-0.003
Growth
Revenue change (TTM)
-14.46%
Earnings per share change (TTM)
315.81%
3-year revenue growth (CAGR)
0.76%
3-year earnings per share growth (CAGR)
-7.24%
Bulls say / Bears say
AirSculpt cut its year-over-year revenue decline by four percentage points from Q1; Q2 revenue fell 13.7% after a 17.3% drop in Q1, showing progress from transformation efforts (SEC Filing).
Net loss in Q2 narrowed to $0.6 million from $3.2 million a year ago, with Adjusted EBITDA holding strong at $5.8 million, reflecting better cost control and operational leverage (SEC Filing).
The balance sheet improved with $16 million of debt repaid in Q2, and liquidity totaling $8.2 million in cash plus $5.0 million of available credit, supporting ongoing growth investment (SEC Filing).
Case volumes continued to decline, with Q2 procedures down 14.1% year-over-year to 3,392 and revenue decreasing 13.7% to $44.0 million, highlighting ongoing weak demand for body contouring procedures (SEC Filing).
Operating cash flow for the first half of the year fell to $5.9 million from $6.8 million a year earlier, indicating reduced cash generation due to lower procedure volumes and revenue (SEC Filing).
The company recorded a net loss of $3.4 million for the first six months of fiscal 2025, compared with net income of $2.8 million in the same period last year, signaling ongoing profitability challenges and margin pressure (SEC Filing).
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AirSculpt Technologies stock?
AirSculpt Technologies (AIRS) has a market cap of $681M as of October 30, 2025.
What is the P/E ratio for AirSculpt Technologies stock?
The price to earnings (P/E) ratio for AirSculpt Technologies (AIRS) stock is 0 as of October 30, 2025.
Does AirSculpt Technologies stock pay dividends?
No, AirSculpt Technologies (AIRS) stock does not pay dividends to its shareholders as of October 30, 2025.
When is the next AirSculpt Technologies dividend payment date?
AirSculpt Technologies (AIRS) stock does not pay dividends to its shareholders.
What is the beta indicator for AirSculpt Technologies?
AirSculpt Technologies (AIRS) has a beta rating of 2.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.